|
Inspiring
Great Partnerships
Inspire's Business
Development Team is committed to building strong and enduring partnerships.
It is of great importance to have the right fit with a partner's portfolio,
people and aspirations. We believe this is the foundation for a successful
alliance.
Our
entire organization is committed to enabling each opportunity to
reach its fullest potential. Our talented research scientists, dedicated
development team and passionate commercial force are committed to
the success of each and every partnership.
|
|
"We
value our current corporate collaborations and look forward
to creating mutually beneficial relationships as we grow our
business. We understand the importance of building and maintaining
strong relationships and strive to be a preferred partner
in the areas of Ophthalmology and Pulmonary. Our matrixed
team approach enables a streamlined and efficient process."
Christy
L. Shaffer, Ph.D.
President
and Chief Executive Officer
|
| |
|
|
"One
of Inspire's competitive advantages is our ability to build
strong and sustainable partnerships. We have been adept in creating
quality collaborations that have contributed to our success
and the success of our partners. We believe this sets us apart
from many of our competitors."
Bart
J. Dunn
Vice President, Business Development
and Strategic Planning |
| |
|
|
"We
view partnering as an important way to enhance our internal
research and development programs. Our team also has the clinical
and regulatory expertise that helps ensure our partner's discovery
will achieve its maximum potential."
Benjamin
J. Yerxa, Ph.D.
Chief Scientific Officer and
Executive
Vice President,
Strategic
Operations
|
| |
Creating
Value through Great Partnerships
Who
We Are
Business
Development is a touchstone to our corporate strategy at Inspire,
and as such, we strive for excellence in our collaborations.
Our in-licensing approach is aligned with our core therapeutic
areas of Ophthalmology and Pulmonary. We target opportunities that
complement or augment our discovery and development programs, the
foundation of Inspire, as well as those that leverage our expanding
commercial capabilities within North America.
Our
approach to collaborations is bimodal. We are interested in alliances
that facilitate expansion of our current product portfolio and those
that enable future commercialization of our pipeline products outside
of North America. The Business Development team reports directly
to the CEO, enabling speed and agility, accessibility and decision-making
authority. It also underscores the commitment to and importance
of this function within the Inspire organization.
Building
on a Record of Proven Results
We strive
to achieve a balanced approach to building Inspire's business and
creating value for our shareholders through our partnerships.
Our current marketed products are the result of successful collaborations
with Allergan, Inc., a global leader in ophthalmology, and InSite
Vision Inc., known for its novel, DuraSite®
drug delivery technology. The Allergan relationship enabled a launch
opportunity with Elestat®
combined with the co-promotion opportunity of Restasis®.
Inspire rapidly established an impressive reputation in the marketplace,
placing us in an excellent position to take on additional commercial
products when the timing and opportunity were right. In 2007, Inspire
licensed-in AzaSite®
from InSite Vision, enabling an expanded presence in the primary
care and pediatric markets.
Our
current product pipeline is characterized by a balanced blend of
compounds from our own research and those from our partnering initiatives.
Diquafosol and denufosol were discovered and developed by Inspire,
based on our extensive, in-house expertise in P2 receptor technology.
Our glaucoma program and epinastine nasal spray are the result of
strategic, in-licensing initiatives with WARF (Wisconsin Alumni
Research Foundation) and Boehringer-Ingelheim International GmbH,
respectively.
Inspire
As Your Partner
Business
Development is dedicated to sharing the Inspire corporate culture
of passion, determination and commitment to excellence with each
of our partners. We are constantly in search of collaborations
that complement our currently marketed and pipeline portfolios,
as well as those that meet a strategic need. Companies that seek
a smaller biopharmaceutical company, dedicated to high quality and
high standards from research through commercialization will find
this throughout Inspire.
Our
partnerships are characterized by strong collaboration and open
communications at all levels throughout the organization. Inspire
cultivates an internal environment that fosters trust and mutual
respect. This strong corporate culture permeates our active Joint
Development and Commercialization Committee interactions with our
strategic partners.
Inspire
takes partnering very seriously. We take pride in the partnerships
we enter into and value the opportunities that are entrusted to
us. We provide valuable discoveries the attention and the commitment
they deserve.
We
believe we are a special biopharmaceutical company; and through
selective partnerships, a balanced approach and sharing our corporate
culture, we strive to ensure ultimate success of our alliances.
Page
last updated: 30-Jul-2008
|
|
|
|
|
|
Copyright
© 1999-2005 Inspire Pharmaceuticals Inc. All rights reserved
|
|
|
|
